scispace - formally typeset
J

Jan G.P. Tijssen

Researcher at University of Amsterdam

Publications -  386
Citations -  27918

Jan G.P. Tijssen is an academic researcher from University of Amsterdam. The author has contributed to research in topics: Myocardial infarction & Percutaneous coronary intervention. The author has an hindex of 82, co-authored 368 publications receiving 24595 citations. Previous affiliations of Jan G.P. Tijssen include University of Hasselt & Icahn School of Medicine at Mount Sinai.

Papers
More filters
Journal ArticleDOI

Global incidences of out-of-hospital cardiac arrest and survival rates: Systematic review of 67 prospective studies.

TL;DR: The weighted incidence estimate was significantly higher in studies including adults than in those including adults and paediatrics for treated OHCAs, and the percentage of VF and survival to discharge rates were lower in Asia than in Europe, North America, Asia, or Australia.
Journal ArticleDOI

Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus.

TL;DR: Although median overall, disease-free, and quality-adjusted survival did not differ statistically between the groups, there was a trend toward improved long-term survival at five years with the extended transthoracic approach.
Journal ArticleDOI

Incidence of Recurrent Thromboembolic and Bleeding Complications Among Patients With Venous Thromboembolism in Relation to Both Malignancy and Achieved International Normalized Ratio: A Retrospective Analysis

TL;DR: Although adequately dosed vitamin K antagonists are effective in patients with malignant disease, the incidence of thrombotic and bleeding complications remains higher than in patients without malignancy.
Journal ArticleDOI

Effects of early high-volume continuous venovenous hemofiltration on survival and recovery of renal function in intensive care patients with acute renal failure: A prospective, randomized trial

TL;DR: In the present study of critically ill patients with oliguric acute renal failure, survival at 28 days and recovery of renal function were not improved using high ultrafiltrate volumes or early initiation of hemofiltration.